Retail network access is facilitated through agreements with United Networks of America (UNA). Display of pharmacy brand marks does not imply ownership, endorsement, or direct partnership with XRP Healthcare M&A Holding Inc.
Technology partnerships reflect collaborative or project-based cooperation. Display does not imply equity ownership or endorsement unless expressly stated.
Pharmaceutical and supply relationships reflect existing commercial arrangements within acquired operating entities. Display does not imply exclusivity or endorsement beyond standard commercial supply agreements.
Advisors provide professional services to XRP Healthcare M&A Holding Inc. No partnership or ownership interest is implied unless publicly disclosed.
All third-party trademarks remain the property of their respective owners. Display does not imply endorsement, ownership, or partnership unless expressly stated.
Jul 18, 2025
As XRP Healthcare moves closer to its anticipated public listing, an important and recurring question has surfaced from within the community: What role does the XRPH token play in all of this? It’s a valid concern - one
As XRP Healthcare moves closer to its anticipated public listing, an important and recurring question has surfaced from within the community: What role does the XRPH token play in all of this? It’s a valid concern - one we’ve touched on before - but it’s worth reiterating with absolute clarity.
XRP Healthcare’s IPO marks blockchain’s bold move into medical M&A.
The XRPH token remains purposeful and active within our broader ecosystem. However, regulatory compliance requires a clear and necessary separation between the token and our upcoming IPO. This isn’t a strategic preference - it’s a legal obligation. Public markets require a distinction between digital assets and the corporate structures of listing entities.
To better understand this structure, look no further than the relationship between Ripple and the XRP token. Ripple has long been rumored to be considering an IPO, but in such a scenario, it would be Ripple the company going public - not XRP the asset.
Despite their shared roots and ecosystem, the two remain legally and operationally independent. The XRP community has largely welcomed Ripple’s growth, recognizing how corporate momentum can positively influence the broader ecosystem without direct token inclusion.
XRP Healthcare’s IPO reflects a similar structure as blockchain continues to expand into healthcare and medical acquisitions.
We find ourselves in a parallel position. Our move toward public listing is designed to strengthen credibility, attract strategic partnerships, and position XRP Healthcare for sustainable global growth.
The XRPH token will not form part of the IPO structure, but that does not diminish its relevance. In fact, as the company gains visibility and expands internationally, the broader ecosystem - including XRPH - may benefit from that momentum.
To summarize: XRPH continues to play a vital role, but the scale of what we are building extends far beyond any single asset.
We are laying the foundation for a scalable, compliant, and impactful healthcare ecosystem - and the token remains an integral part of that long-term vision, even if it is not directly involved in the public listing.